Development Level

Tbio 16 | 10,625
Tchem 10 | 1,890
Tclin 4 | 602
Tdark 1 | 7,003

Disease

ovarian cancer 17 | 8,484
osteosarcoma 13 | 7,933
glioblastoma 12 | 5,572
psoriasis 11 | 6,685
malignant mesothelioma 9 | 3,162
intraductal papillary-mucinous neoplasm (IPMN) 8 | 3,289
lung cancer 8 | 4,466
medulloblastoma, large-cell 8 | 6,234
pancreatic cancer 8 | 2,300
diabetes mellitus 7 | 1,663
intraductal papillary-mucinous adenoma (IPMA) 7 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 7 | 2,988
Cancer 6 | 2,346
Glycogen storage disease 6 | 37
pancreatic ductal adenocarcinoma liver metastasis 6 | 1,795
pediatric high grade glioma 6 | 2,712
Carcinoma 5 | 2,147
Galactosemia 5 | 20
Obesity 5 | 616
adult high grade glioma 5 | 2,148
astrocytoma 5 | 1,493
colon cancer 5 | 1,475
lung adenocarcinoma 5 | 2,713
pilocytic astrocytoma 5 | 3,086
tuberculosis 5 | 1,557
Multiple myeloma 4 | 1,327
Myocardial Ischemia 4 | 169
atypical teratoid / rhabdoid tumor 4 | 4,369
cystic fibrosis 4 | 1,665
ductal carcinoma in situ 4 | 1,745
group 3 medulloblastoma 4 | 2,254
group 4 medulloblastoma 4 | 1,875
lung carcinoma 4 | 2,844
non-small cell lung cancer 4 | 2,798
posterior fossa group A ependymoma 4 | 1,511
subependymal giant cell astrocytoma 4 | 2,287
Breast cancer 3 | 3,094
Cataract 3 | 104
Diabetes Mellitus, Experimental 3 | 106
Diabetes mellitus type 2 3 | 69
Diarrhea 3 | 155
Galactosemias 3 | 3
Hyperglycemia 3 | 120
Kidney disease 3 | 396
Metabolic syndrome X 3 | 155
Neuropathy 3 | 210
Type 2 diabetes mellitus 3 | 189
active ulcerative colitis 3 | 477
adrenocortical carcinoma 3 | 1,427
breast carcinoma 3 | 1,614
dermatomyositis 3 | 933
invasive ductal carcinoma 3 | 2,950
primary pancreatic ductal adenocarcinoma 3 | 1,271
primitive neuroectodermal tumor 3 | 3,031
ulcerative colitis 3 | 2,087
Acquired metabolic disease 2 | 267
Atopic dermatitis 2 | 944
Cardiomyopathy 2 | 110
Cerebrovascular disease 2 | 231
Congenital disorder of glycosylation 2 | 53
Contact Dermatitis 2 | 80
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Diabetic complication 2 | 3
Diabetic neuropathy 2 | 8
Endometrial Neoplasms 2 | 50
Fabry disease 2 | 9
Fabry's disease 2 | 2
Gangliosidosis 2 | 17
Gaucher's disease 2 | 24
Gestational Diabetes 2 | 17
Glucosylceramide beta-glucosidase deficiency 2 | 4
Glycogen storage disease II 2 | 7
Glycoproteinosis 2 | 13
Hyperinsulinism 2 | 63
Hyperuricemia 2 | 35
Hypoglycemia 2 | 81
Insulinoma 2 | 20
Krabbe disease 2 | 11
Mucopolysaccharidosis 2 | 24
Myopathy 2 | 128
Neurodegenerative disease 2 | 383
Neutropenia 2 | 78
Osteoporosis 2 | 257
Rheumatoid Arthritis 2 | 1,160
Waldenstrons macroglobulinemia 2 | 765
astrocytic glioma 2 | 2,241
atypical teratoid/rhabdoid tumor 2 | 1,095
ependymoma 2 | 2,514
gastric carcinoma 2 | 832
hepatocellular carcinoma 2 | 532
interstitial cystitis 2 | 2,299
medulloblastoma 2 | 1,524
mucosa-associated lymphoid tissue lymphoma 2 | 480
nephrosclerosis 2 | 329
oligodendroglioma 2 | 2,849
pituitary cancer 2 | 1,972
tuberculosis and treatment for 6 months 2 | 686
Bilirubin metabolic disorder 1 | 39
Celiac disease 1 | 112
Typhoid fever 1 | 22

Tissue

Blood and immune system 31 | 17,995
Cardiovascular System 31 | 17,958
Digestive Tract 31 | 18,473
Endocrine System 31 | 18,512
Female tissues 31 | 18,647
Nervous System 31 | 18,561
Skin and soft tissues 31 | 18,115
Urinary Tract 31 | 18,444
Liver and Pancreas 30 | 18,136
Male tissues 29 | 17,969
Respiratory system 29 | 17,484

Target Family

Enzyme 22 | 4,146
Kinase 9 | 634

KEGG Pathway

Galactose metabolism 31 | 31
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
ATP-dependent 6-phosphofructokinase, platelet type PFKP Tbio Kinase -1.89344 74.7 268
Galactokinase GALK1 Tbio Kinase -2.55983 362.5 175
Maltase-glucoamylase, intestinal MGAM Tclin Enzyme -4.44117 27956.4 30
Hexokinase-2 HK2 Tchem Kinase -2.57126 391.1 373
Sucrase-isomaltase, intestinal SI Tchem Enzyme -1.82396 67.3 52
Hexokinase-3 HK3 Tbio Kinase -1.68683 47.9 299
Aldose reductase AKR1B1 Tclin Enzyme -3.24467 1851.0 302
Beta-1,4-galactosyltransferase 1 B4GALT1 Tbio Enzyme -2.28449 197.5 112
ATP-dependent 6-phosphofructokinase, liver type PFKL Tbio Kinase -2.04564 104.4 212
Glucose-6-phosphatase 3 G6PC3 Tbio Enzyme -1.51146 36.0 43